98 related articles for article (PubMed ID: 22665576)
21. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
Howell LP; Gurusinghe S; Tabnak F; Sciortino S
Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
[TBL] [Abstract][Full Text] [Related]
22. A screening programme for cervical cancer that worked.
Hakama M; Louhivuori K
Cancer Surv; 1988; 7(3):403-16. PubMed ID: 3242792
[TBL] [Abstract][Full Text] [Related]
23. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
[TBL] [Abstract][Full Text] [Related]
24. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
[TBL] [Abstract][Full Text] [Related]
25. Cervical cancer screening. Past success and future challenge.
Dewar MA; Hall K; Perchalski J
Prim Care; 1992 Sep; 19(3):589-606. PubMed ID: 1410065
[TBL] [Abstract][Full Text] [Related]
26. Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.
Lewis H; Yeh LC; Almendral B; Neal H
N Z Med J; 2009 Oct; 122(1305):15-25. PubMed ID: 19966874
[TBL] [Abstract][Full Text] [Related]
27. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
28. Results from a cervical cancer screening programme in Manitoba, Canada.
Choi NW; Nelson NA
IARC Sci Publ; 1986; (76):61-7. PubMed ID: 3570416
[No Abstract] [Full Text] [Related]
29. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.
Kim JJ; Leung GM; Woo PP; Goldie SJ
J Public Health (Oxf); 2004 Jun; 26(2):130-7. PubMed ID: 15284314
[TBL] [Abstract][Full Text] [Related]
30. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
31. What happens when organization of cervical cancer screening is delayed or stopped?
Lynge E; Clausen LB; Guignard R; Poll P
J Med Screen; 2006; 13(1):41-6. PubMed ID: 16569305
[TBL] [Abstract][Full Text] [Related]
32. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri.
Nieminen P; Kallio M; Hakama M
Obstet Gynecol; 1995 Jun; 85(6):1017-21. PubMed ID: 7770247
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of the cervical cancer prevention programme: a case-control mortality audit in Lithuania.
Everatt R; Kuzmickienė I; Intaitė B; Anttila A
Eur J Cancer Prev; 2020 Nov; 29(6):504-510. PubMed ID: 32932287
[TBL] [Abstract][Full Text] [Related]
34. High lifetime probability of screen-detected cervical abnormalities.
Pankakoski M; Heinävaara S; Sarkeala T; Anttila A
J Med Screen; 2017 Dec; 24(4):201-207. PubMed ID: 28073308
[TBL] [Abstract][Full Text] [Related]
35. Impact of opportunistic screening on squamous cell and adenocarcinoma of the cervix in Germany: A population-based case-control study.
Tanaka LF; Schriefer D; Radde K; Schauberger G; Klug SJ
PLoS One; 2021; 16(7):e0253801. PubMed ID: 34260601
[TBL] [Abstract][Full Text] [Related]
36. Why Do Women Get Cervical Cancer in an Organized Screening Program in Canada?
Jackson R; Wang L; Jembere N; Murphy J; Kupets R
J Low Genit Tract Dis; 2019 Jan; 23(1):1-6. PubMed ID: 30489433
[TBL] [Abstract][Full Text] [Related]
37. Effect of Test History at Ages 50-64 on Later Cervical Cancer Risk: A Population-based Case-control Study.
Kultalahti H; Heinävaara S; Sarkeala T; Pankakoski M
Cancer Res Commun; 2023 Sep; 3(9):1823-1829. PubMed ID: 37700796
[TBL] [Abstract][Full Text] [Related]
38. Improving cervical cancer screening attendance in Finland.
Virtanen A; Anttila A; Luostarinen T; Malila N; Nieminen P
Int J Cancer; 2015 Mar; 136(6):E677-84. PubMed ID: 25178683
[TBL] [Abstract][Full Text] [Related]
39. Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.
Castañón A; Landy R; Cuzick J; Sasieni P
PLoS Med; 2014 Jan; 11(1):e1001585. PubMed ID: 24453946
[TBL] [Abstract][Full Text] [Related]
40. Cervical cancer screening in Japan. A case-control study.
Sato S; Makino H; Yajima A; Fukao A
Acta Cytol; 1997; 41(4):1103-6. PubMed ID: 9250306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
